BMO Capital raised the firm’s price target on IBM (IBM) to $300 from $260 and keeps a Market Perform rating on the shares. The new Z17 can help drive growth over the next two fiscal years, the analyst tells investors in a research note. Over the longer term, BMO continues to think mainframe will have limited growth, as the firm does not envision IBM winning meaningful AI workloads.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBM:
- How IBM and Moderna (MRNA) Are Using Quantum Computing to Design Vaccines Faster
- IBM price target raised to $315 from $285 at RBC Capital
- Rigetti Stock (RGTI) Explodes after Hitting Key Quantum Milestone
- IBM price target raised to $310 from $290 at Stifel
- IBM price target raised to $253 from $233 at Morgan Stanley